Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Sionna Therapeutics, Inc.

Report topline data for SION-719 Phase 2a trial

Delivered after the deadline (41 days after the deadline)

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
4 Jun 2025
Due
30 Jun 2026
Delivered
10 Aug 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“with topline data anticipated in mid-2026”

What we found

Evidence strength A What the grades mean

The company reported topline data for the SION-719 Phase 2a trial on August 10, 2026, which is after the mid-2026 deadline.

  • A
    Sionna Therapeutics, Inc. 8-K filed 2026-08-10 Regulatory filing · published 10 Aug 2026 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint 1956ee0bec4a
    “Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update SION-719 Phase 2a proof-of-concept trial did not achieve key activity endpoint” ✓ confirmed on the page

Market reaction: the shares moved -87.7% against the S&P 500 over the three sessions around the disclosure (7 Aug 2026 to 12 Aug 2026). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
topline data for SION-719 Phase 2a trial
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Sionna Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-SION-001957 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.